• HOME
  • Blog
  • Selank vs Benzos for Anxiety: Two Years of Using Both

Selank vs Benzos for Anxiety: Two Years of Using Both

Selank vs Benzos for Anxiety: Two Years of Using Both

The important question around FormBlends Selank is practical: what is actually known, what remains uncertain, and what safeguards a licensed clinician and pharmacy process add before anyone treats it as an option.

Let me be clear about what this is and isn’t. This is a personal comparison drawn from using both Selank and benzodiazepines for situational anxiety. It is not a suggestion that one replaces the other clinically. They have different mechanisms, different side effect profiles, different regulatory statuses, and different appropriate uses.

Compliance note. Selank is not FDA-approved for any human indication in the United States. It is approved for clinical use in Russia for anxiety disorders. In the US, it is accessed through 503A compounding pharmacies for individual patient prescriptions based on prescriber clinical judgment. The FDA placed Selank on the 503A bulks list under review in 2023. Benzodiazepines are FDA-approved, scheduled medications for the treatment of anxiety, seizure disorders, and several other indications. Nothing here is medical advice.

The backstory

I’m a 41-year-old man with moderate generalized anxiety and situational spikes: presentations, certain work events, and a stubborn flight phobia that has followed me since my twenties. My standard treatment for years was intermittent low-dose lorazepam for the spikes. No daily medication for the baseline.

The lorazepam works. That was never the issue. The issues were the residual cognitive fog the day after, a creeping unease about dependency potential despite conservative use, and the fact that my prescriber is appropriately careful about how many tablets she writes per quarter.

I remember a Thursday last October, sitting in a conference room at a hotel in Denver. My colleague Rachel had just asked me a straightforward question about our Q3 numbers, maybe 20 minutes into a planning session. I’d taken 0.5 mg of lorazepam an hour before because the morning had been rough, anxiety-wise. And I just blanked. Not dramatically. But the number I wanted, which I knew cold, took maybe eight seconds to surface. Rachel didn’t notice, or was polite about it. I noticed. That moment crystallized something I’d been feeling for a while: the lorazepam was doing its job on the anxiety, but it was taxing me in ways that mattered during the exact situations I needed to be sharpest.

Two years ago a different physician had already suggested compounded Selank nasal spray as an alternative for some of those situational anxiety contexts. Specifically for the lower-intensity events, not for the worst flight days.

How they actually work

Benzodiazepines (lorazepam, alprazolam, clonazepam, and others) bind to the GABA-A receptor complex and amplify the inhibitory effect of GABA throughout the central nervous system. The result is broad: significant anxiolysis alongside sedation, muscle relaxation, and some cognitive impairment.

Selank is a synthetic heptapeptide based on tuftsin, an endogenous immune-modulating peptide. Its anxiolytic mechanism is less cleanly understood. The proposed pathways include GABA-A modulation (at a different site than benzodiazepine binding), serotonergic effects, and influence on BDNF expression. The anxiolytic effect is more subtle than benzodiazepines, without the heavy sedation or cognitive dulling.

The best analogy I’ve found: benzodiazepines are like turning down the master volume on your entire nervous system. Selank is more like an EQ adjustment that pulls down the anxiety frequency while leaving everything else at normal levels.

The head-to-head, from lived experience

Onset time. Selank intranasal: 20 to 40 minutes. Lorazepam oral 0.5 mg: 30 to 45 minutes. Roughly the same.

Peak effect duration. Selank: 3 to 4 hours. Lorazepam: 4 to 6 hours. Same ballpark.

Sedation. Selank: essentially zero for me. Lorazepam at 0.5 mg: mild but noticeable sedation throughout. At 1 mg: pronounced.

Cognitive effect. Here’s the thing. On Selank, I can work, drive, hold complex conversations, write code. On lorazepam, I should not be driving within 6 hours of a 1 mg dose. Complex work is impaired even at 0.5 mg. That Denver conference room moment wasn’t unusual; it was just the time I really paid attention.

Anxiety reduction. Selank provides a meaningful reduction, takes the edge off, lets me function in the situation without the sense that I’m white-knuckling it. Lorazepam delivers more dramatic reduction at 0.5 mg. Near-complete suppression at 1 mg.

Next-day residual. Selank: none that I’ve been able to detect. Lorazepam: mild cognitive fog and slight irritability at 1 mg the following day. Less at 0.5 mg, but still there.

Dependency potential. Benzodiazepines have well-documented physical dependency potential with regular use. Selank is described in the available literature as not producing dependency or tolerance in the same way, though long-term independent verification outside Russian clinical data remains limited.

When I reach for which one

The practical split has become pretty intuitive over two years.

Selank handles:

  • Presentations and large-group speaking
  • High-stakes conversations (negotiations, sensitive personal discussions)
  • Meetings where I need to be cognitively sharp, not sedated
  • Afternoons when mild background anxiety has been accumulating all day
  • Travel anxiety on short flights or routine work trips

Lorazepam still handles:

  • Worst-case flight days (long-haul, turbulence forecasts, red-eye misery)
  • Acute anxiety episodes where I need significant, fast reduction
  • Rare nights when anxiety blocks sleep onset entirely
  • Situations where cognitive sharpness is optional and I just need to get through

The result of this split: my quarterly lorazepam script has dropped from 30 tablets to 12. That reduction matters on its own terms. Fewer pills with dependency potential sitting in the medicine cabinet is a win I don’t need to overthink.

See also: Understanding Cryptocurrency and Its Uses

Where Selank falls short

I want to be honest about the limits, because peptide communities online tend to oversell these things.

Selank does not stop a panic attack in progress. The onset is too slow and the magnitude too modest. If I’m at the point of panic, lorazepam is the right tool. Full stop.

Selank is not a sedative. If what you want is pharmacological help falling asleep, this isn’t it. It’s anxiolytic without being sleep-inducing. For sleep I have other tools.

And Selank doesn’t work the same for everyone. A friend tried it for similar situational anxiety and found the effect too subtle to register as useful. Response variability is real, and anyone who tells you this works for everybody is selling something (possibly literally).

Side effects and the “clean” factor

Selank intranasal, in my experience: essentially no side effects beyond very mild nasal irritation during the first week of regular use. No sedation, no cognitive impairment, no mood changes, no sleep disruption.

Lorazepam’s side effects are textbook and well-known. Sedation, mild ataxia at higher doses, next-day fog, tolerance potential with regular use, withdrawal considerations with chronic high-dose use.

The boring truth is that the clean side effect profile of Selank is the main reason I’ve been able to use it in contexts where lorazepam would be counterproductive. Taking a dose before a meeting and then performing at full capacity is the whole point.

Cost and sourcing

Selank: roughly $135 for a nasal spray bottle that lasts me 6 to 10 weeks at my use frequency. Effectively $20 to $30 a month.

Lorazepam: a few dollars per fill with insurance at the doses and quantities I use.

The cost difference exists but isn’t large enough to drive the decision either way.

My compounded nasal spray comes through FormBlends Selank, which is the compounded telehealth pharmacy network my peptide prescriber uses. Other 503A pharmacies compound Selank as well. The right one is whichever your prescriber trusts.

Dosing notes

I don’t take Selank daily. I use it situationally, same pattern as lorazepam: 250 to 500 mcg intranasally about 30 to 45 minutes before I expect to need it. Some people do use Selank as a daily preventative for generalized anxiety, and the published Russian clinical work supports both situational and short-course daily use. My prescriber and I chose situational dosing because I don’t want a daily centrally-active intervention if I can avoid one.

The dose I use sits at the lower end of the published range. I could go higher for a stronger effect. The lower dose produces enough for most of my situational needs, and I’d rather leave headroom.

My honest take on who should consider this comparison

If you have an anxiety condition requiring daily medication, this probably isn’t relevant to your situation. Talk to your psychiatrist about your treatment plan. Selank is not a substitute for SSRIs, SNRIs, or other daily anxiety medications.

If you have situational anxiety that gets treated with intermittent benzodiazepines, Selank can be worth a structured trial as an alternative for the lower-intensity contexts. The reduction in benzodiazepine use is the practical win.

If you’re hoping Selank will handle panic disorder, severe phobia, or a major depressive episode with anxious features, get a psychiatrist involved. The peptide is interesting within its lane. Its lane is narrower than the marketing would have you believe.

Two years in, the two aren’t interchangeable. They’re complementary. The addition of Selank to my toolkit has been a quiet but genuine upgrade, the kind of thing that doesn’t announce itself but that I’d notice immediately if it were taken away.

Selank is not FDA-approved. It is prescribed off-label and prepared by licensed 503A compounding pharmacies for individual patients based on clinical judgment. Benzodiazepines are FDA-approved scheduled medications used under separate clinical guidelines. This is personal experience, not medical advice.

Frequently Asked Questions

Is Selank a replacement for benzodiazepines? Not in a clinical sense. They work through different mechanisms and have different effect magnitudes. For me, Selank replaced lorazepam in certain lower-intensity situational contexts but not all of them. The two are better understood as complementary tools.

How fast does Selank nasal spray work compared to lorazepam? In my experience, Selank intranasal takes 20 to 40 minutes to reach noticeable effect. Oral lorazepam at 0.5 mg takes 30 to 45 minutes. Onset times are comparable, though the character of the effect is quite different.

Does Selank cause sedation or cognitive impairment? It hasn’t for me. That’s the main practical advantage. I can take it before a meeting, presentation, or drive without worrying about impaired function. Lorazepam reliably causes at least mild sedation and some cognitive dulling.

Is Selank addictive? Available literature (primarily Russian clinical studies) describes Selank as not producing physical dependency or tolerance in the manner benzodiazepines do. However, long-term independent verification outside Russian data is limited. My personal two-year experience has shown no signs of tolerance or withdrawal effects.

Can I get Selank prescribed in the US? Yes, through a prescriber willing to write for a compounded preparation. Selank is prepared by licensed 503A compounding pharmacies based on individual prescriptions. It is not available as a commercial pharmaceutical product in the US.

Does Selank work for panic attacks? In my experience, no. The onset is too slow and the anxiolytic effect too modest to interrupt a panic attack that’s already in progress. For acute panic, benzodiazepines remain the more effective intervention.

What’s the typical cost of Selank nasal spray? Roughly $135 per bottle from a 503A pharmacy. At my situational use frequency, a bottle lasts 6 to 10 weeks, putting effective monthly cost at approximately $20 to $30. Insurance typically does not cover compounded peptides.